Safest Antihistamines for Children
Second-generation antihistamines (cetirizine, loratadine, desloratadine, fexofenadine, and levocetirizine) are the safest options for children and should be used preferentially over first-generation antihistamines. 1
Critical Safety Distinction by Generation
Second-Generation Antihistamines (SAFEST)
Second-generation antihistamines have been shown to be well-tolerated with an excellent safety profile in young children 1. These agents are:
- More selective for peripheral H1 receptors, minimizing central nervous system effects
- Non-sedating or minimally sedating
- Free from cognitive impairment that affects school performance and driving ability
- Lacking anticholinergic side effects
The ARIA guidelines strongly recommend new-generation oral H1-antihistamines that do not cause sedation and do not interact with cytochrome P450 2.
First-Generation Antihistamines (AVOID)
First-generation antihistamines should be avoided in children due to significant safety concerns 1:
- Between 1969-2006, there were 69 pediatric fatalities associated with first-generation antihistamines (diphenhydramine: 33, chlorpheniramine: 27, brompheniramine: 9), with 41 deaths occurring below age 2 years 1
- Cause marked sedation, cognitive impairment, and learning difficulties
- Impair school performance without subjective awareness of sedation
- Associated with increased automobile accidents in adolescents
- Produce anticholinergic effects (dry mouth, constipation, urinary retention)
Age-Specific Recommendations
Children Under 6 Months
- Cetirizine is approved down to 6 months of age 3
- Limited data available; use only when clearly indicated
Children 6 Months to 2 Years
- Cetirizine (approved from 6 months): 0.25 mg/kg twice daily 3
- Levocetirizine (approved from 6 months): demonstrated safety over 18 months in children aged 1-3 years with no adverse effects on physical or psychomotor development 4
- Avoid OTC cough and cold medications containing antihistamines below age 2 years due to toxicity risk 1
Children 2-6 Years
- Cetirizine: 2.5-5 mg daily
- Loratadine: 5 mg daily
- Desloratadine: 2.5 mg daily
- These are the only second-generation antihistamines approved for children under 5 years 5
Children 6-12 Years
- Cetirizine: 5-10 mg daily
- Loratadine: 10 mg daily
- Desloratadine: 5 mg daily
- Fexofenadine: 30 mg twice daily
- Levocetirizine: 5 mg daily
Specific Safety Data by Agent
Cetirizine has the most robust pediatric safety data, including the only randomized, double-blind, placebo-controlled study in infants 6-11 months showing no CNS or cardiac effects 3.
Levocetirizine is the most extensively investigated H1-antihistamine in children aged 2-12 years and is the only agent with 18-month safety data in children 1-3 years old showing no effects on physical/psychomotor development 4.
Critical Pitfalls to Avoid
Never use first-generation antihistamines (diphenhydramine, chlorpheniramine, brompheniramine) for routine allergic conditions in children due to mortality risk and cognitive impairment 1
Avoid OTC cough/cold combination products in children under 6 years—these are ineffective for upper respiratory infections and carry overdose risk from multiple product use 1
Do not use antihistamines for asthma prevention in infants with atopic dermatitis or family history of allergy—evidence shows no benefit 2
Beware of dosing errors: Most pediatric antihistamine fatalities resulted from medication errors, use of multiple products simultaneously, or accidental exposures 1
Practical Prescribing Algorithm
For any child with allergic symptoms:
- Choose a second-generation antihistamine based on age approval
- For children 6 months-2 years: Use cetirizine or levocetirizine only
- For children 2-5 years: Add loratadine and desloratadine as options
- For children ≥6 years: All second-generation agents are appropriate
- Never prescribe first-generation antihistamines for routine use
- Counsel families to avoid OTC cough/cold products in children under 6 years